Feasibility of biweekly combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in patients with metastatic solid tumors: results of a two-step phase I trial: XELIRI and XELIRINOX
Publication:
Cancer Chemotherapy and Pharmacology
Publisher:
Springer Nature
Copyright © 2011, Springer-Verlag